Alternate Day Buprenorphine Administration, Phase X - 15

National Institutes of Health (NIH)

Status and phase: Completed; Phase 2

Conditions: Opioid-Related Disorders

Treatments: Drug: Buprenorphine

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT00000233

NIDA-06969-15

R01-06969-15

Details and patient eligibility

About

The purpose of this study is to determine how subjects will make changes in the amount of medication received when given a monetary alternative to buprenorphine.

Sex: All

Ages: 34 to 51 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Please contact site for information.